Eric Ong is an associate in the San Francisco office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm's patents and innovations group. He focuses on patent prosecution and intellectual property counseling in the fields of bioengineering, biotechnology, and antibody and protein therapeutics.
During law school, Eric participated in the Startup Legal Garage, where he conducted freedom-to-operate analyses for biotechnology start-ups and California state agencies. He was also a Chancellor’s Scholar and an Innovation Law Clinic Scholar, and served on the executive board of the Law & Intellectual Property Association.
Prior to joining the firm, Eric was a protein biochemist at Regeneron Pharmaceuticals, where he studied antibody size and charge variants, and protein-ligand interactions. During his studies at the Johns Hopkins University, Eric performed research on utilizing a 3D tumor spheroid system to predict tumor cell responsiveness to cancer therapeutics and personalized therapies.
Eric Ong is an associate in the San Francisco office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm's patents and innovations group. He focuses on patent prosecution and intellectual property counseling in the fields of bioengineering, biotechnology, and antibody and protein therapeutics.
During law school, Eric participated in the Startup Legal Garage, where he conducted freedom-to-operate analyses for biotechnology start-ups and California state agencies. He was also a Chancellor’s Scholar and an Innovation Law Clinic Scholar, and served on the executive board of the Law & Intellectual Property Association.
Prior to joining the firm, Eric was a protein biochemist at Regeneron Pharmaceuticals, where he studied antibody size and charge variants, and protein-ligand interactions. During his studies at the Johns Hopkins University, Eric performed research on utilizing a 3D tumor spheroid system to predict tumor cell responsiveness to cancer therapeutics and personalized therapies.
- J.D., University of California College of the Law, San Francisco, 2023Cum Laude; UC Law SF Honor Society; Senior Development Editor, UC Law Journal; CALI Awards in Patent Law, Patent Prosecution Seminar, Criminal Procedure, Legal Research & Writing
- M.S.E., Chemical and Biomolecular Engineering, Johns Hopkins University, 2017
- B.S., Chemical and Biomolecular Engineering, Johns Hopkins University, 2016
- State Bar of California
- U.S. Patent and Trademark Office
- J.D., University of California College of the Law, San Francisco, 2023Cum Laude; UC Law SF Honor Society; Senior Development Editor, UC Law Journal; CALI Awards in Patent Law, Patent Prosecution Seminar, Criminal Procedure, Legal Research & Writing
- M.S.E., Chemical and Biomolecular Engineering, Johns Hopkins University, 2017
- B.S., Chemical and Biomolecular Engineering, Johns Hopkins University, 2016
- State Bar of California
- U.S. Patent and Trademark Office
Select Publications
- Co-author, “Current controversy around the waiver of intellectual property rights for COVID-19 Vaccines and implications for life sciences companies,” The Life Sciences Lawyer Magazine, July 2022
Select Publications
- Co-author, “Current controversy around the waiver of intellectual property rights for COVID-19 Vaccines and implications for life sciences companies,” The Life Sciences Lawyer Magazine, July 2022
- Privacy Policy
- Terms of Use
- Accessibility